Skip to main content
OpenTrials
Completed

NCT Number: NCT04922034

Outcome of Patients After a Negative Oral Challenge to Amoxicillin

This study aims to evaluate the outcome of patients who had a negative oral challenge to Amoxicillin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Negative Challenge to Amoxicillin

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU

Angers, Maine Et Loire, 49933, France

About this study

This is a prospective, single-center, non-interventional study of patients with negative Amoxicillin oral challenge performed at Angers University Hospital between 2017 and 2019.

An information letter indicating the purpose of the study is sent to eligible patients. If they do not object, patients are contacted by telephone to answer the questionnaire. This questionnaire concerns the reintroduction of penicillins at home after the challenge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients whith a negative challenge to Amoxicillin in the Allergology Department of the CHU of Angers between 2017 and 2019.
  • Major patients.

Exclusion criteria

  • Poor comprehension of the French language or cognitive disorders affecting the reliability of the questionnaire
  • Person objecting to participate in this research and to the processing of their medical data

Treatment and study plan

Amoxicillin

Drug

Outcome of patients with negative oral challenge to amoxicillin

Primary outcomes

  1. Resumption of Amoxicillin after a negative oral challenge to Amoxicillin

    Time frame: Oral challenge test oxxuring between 2017 and 2019, and follow-up until the day of the call

    The main objective is to know if patients who had a negative test for reintroduction of Amoxicillin, have resumed this molecule afterwards.

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Registry information

Official study title

Study of Patient's Outcomes After a Negative Reintroduction Test for Amoxicillin

Acronym: REINAD

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 10, 2021
Registry last updated
Sep 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.